drugset / Trial / NCT03625531

A Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on Live Birth in Women With PCOS

NCT03625531

Phase 3 Completed 1103 enrolled Hongxia Ma
RandomizedParallel-groupTriple-blindTreatment

Summary

This study is a randomized assessor-blind controlled trial. A total of 1,103 women with PCOS will be recruited from 20 hospitals and randomly allocated into four groups: personalized acupuncture, fixed acupuncture, letrozole or placebo letrozole. Patients will receive treatment for 16 weeks and the primary outcome is live birth.

Timeline

Start
2018-08-13
Primary completion
2025-01-22
Completion
2025-01-22

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Letrozole Other / unclassified 5 mg
Comparator Letrozole Other / unclassified 7.5 mg